The association of aldosterone and endothelin-1 with incident diabetes among African Americans: The Jackson Heart Study

[1]  M. Sims,et al.  The role of aldosterone and ideal cardiovascular health in incident diabetes: The Jackson Heart Study , 2023, American journal of preventive cardiology.

[2]  A. Peters,et al.  Associations of the vasoactive peptides CT-proET-1 and MR-proADM with incident type 2 diabetes: results from the BiomarCaRE Consortium , 2022, Cardiovascular Diabetology.

[3]  E. Gregg,et al.  New directions in incidence and prevalence of diagnosed diabetes in the USA , 2019, BMJ Open Diabetes Research & Care.

[4]  M. Cushman,et al.  Ideal cardiovascular health, glycaemic status and incident type 2 diabetes mellitus: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study , 2019, Diabetologia.

[5]  W. Hsueh,et al.  Renin‐Angiotensin‐Aldosterone System, Glucose Metabolism and Incident Type 2 Diabetes Mellitus: MESA , 2018, Journal of the American Heart Association.

[6]  W. Hsueh,et al.  Modifiable Lifestyle Risk Factors and Incident Diabetes in African Americans. , 2017, American journal of preventive medicine.

[7]  M. Carnethon,et al.  The association of ideal cardiovascular health with incident type 2 diabetes mellitus: the Multi-Ethnic Study of Atherosclerosis , 2016, Diabetologia.

[8]  U. Lindblad,et al.  Endothelin-1 as a predictor of impaired glucose tolerance and type 2 diabetes--A longitudinal study in the Vara-Skövde Cohort. , 2016, Diabetes Research and Clinical Practice.

[9]  A. Correa,et al.  Aldosterone, Renin, and Diabetes Mellitus in African Americans: The Jackson Heart Study. , 2016, The Journal of clinical endocrinology and metabolism.

[10]  M. Moroi,et al.  Higher circulatory level of endothelin-1 in hypertensive subjects screened through a cross-sectional study of rural Bangladeshi women , 2013, Hypertension Research.

[11]  J. M. Luther.  Effects of aldosterone on insulin sensitivity and secretion , 2014, Steroids.

[12]  Keith C. Norris,et al.  African Americans, hypertension and the renin angiotensin system. , 2014, World journal of cardiology.

[13]  R. Vasan,et al.  Aldosterone, C-Reactive Protein, and Plasma B-Type Natriuretic Peptide Are Associated With the Development of Metabolic Syndrome and Longitudinal Changes in Metabolic Syndrome Components , 2013, Diabetes Care.

[14]  T. Gustafsson,et al.  Endothelin-1 Reduces Glucose Uptake in Human Skeletal Muscle In Vivo and In Vitro , 2011, Diabetes.

[15]  D. Mozaffarian,et al.  Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal Through 2020 and Beyond , 2010, Circulation.

[16]  P. O S I T I O N S T A T E M E N T,et al.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[17]  A. Baron,et al.  Endothelin Limits Insulin Action in Obese/Insulin-Resistant Humans , 2007, Diabetes.

[18]  G. Bakris,et al.  Review: Insulin and endothelin: an interplay contributing to hypertension development? , 2007, The Journal of clinical endocrinology and metabolism.

[19]  R. DeFronzo,et al.  Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases , 2006, Diabetes/metabolism research and reviews.

[20]  M. Drazner,et al.  Left Ventricular Hypertrophy Is More Prevalent in Blacks Than Whites in the General Population: The Dallas Heart Study , 2005, Hypertension.

[21]  Daniel W. Jones,et al.  Toward resolution of cardiovascular health disparities in African Americans: design and methods of the Jackson Heart Study. , 2005, Ethnicity & disease.

[22]  Gregory Evans,et al.  Laboratory, Reading Center, and Coordinating Center Data Management Methods in the Jackson Heart Study , 2004, The American journal of the medical sciences.

[23]  K. Takahashi,et al.  Elevated plasma endothelin in patients with diabetes mellitus , 1990, Diabetologia.

[24]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[25]  Q. Zhong,et al.  Regulation of adiponectin secretion by endothelin-1. , 2003, Biochemical and biophysical research communications.

[26]  D. Jacobs,et al.  Correlates of urinary albumin excretion in young adult blacks and whites: the Coronary Artery Risk Development in Young Adults Study. , 2003, American journal of epidemiology.

[27]  A. Hevener,et al.  Chronic endothelin-1 treatment leads to insulin resistance in vivo. , 2003, Diabetes.

[28]  F. Brancati,et al.  Blood pressure in young adulthood and the risk of type 2 diabetes in middle age. , 2003, Diabetes care.

[29]  J. Olefsky,et al.  Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes. , 2001, The Journal of clinical investigation.

[30]  A. Folsom,et al.  Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study. , 2000, JAMA.

[31]  F. Nieto,et al.  Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus , 2000 .

[32]  A. Pessina,et al.  Interactions between endothelin-1 and the renin–angiotensin–aldosterone system , 1999 .

[33]  G. Ahlborg,et al.  Exogenous endothelin-1 causes peripheral insulin resistance in healthy humans. , 1997, Acta physiologica Scandinavica.

[34]  G. Albertin,et al.  Endothelin adrenocortical secretagogue effect is mediated by the B receptor in rats. , 1996, Hypertension.